ALX Oncology

NCT05467670

Collaborator, Phase 2, Active, not recruiting, 2023, 16 people, 20 Jul 2022, clinicaltrials.gov

NCT04755244

Phase 1, Terminated, 2021, 14 people, 16 Feb 2021, clinicaltrials.gov

NCT04675333

Phase 2, Active, not recruiting, 2021, 172 people, 19 Dec 2020, clinicaltrials.gov

NCT03013218

Phase 1, Completed, 2017, 174 people, 6 Jan 2017, clinicaltrials.gov

Association between rheumatoid arthritis, frailty status, mortality and anti-cancer therapy: a retrospective SEER-Medicare analysis in patients with non-metastatic renal cell carcinoma

Grants or research support, 11 Aug 2026, pubmed.ncbi.nlm.nih.gov